Javascript must be enabled to continue!
Olanzapine Abuse
View through CrossRef
Olanzapine is a thienobenzodiazepine that blocks especially the serontonin (5-hydroxytryptamine [5-HT]) 5-HT2A and the dopamine D2 receptors as well as muscarinic (M1), histamine (H1), 5-HT2C, 5-HT3 to 5-HT6, adrenergic (αl), and D4 receptors. This case report presents an olanzapine abuse. A 48-year-old, primary school graduate, married woman applied to psychiatry clinic with tachycardia, insomnia, and anxiety complaints. In psychiatric evaluations, it was determined that these complaints have been continuing for 15 years at intervals and that she has been using citalopram 40 mg/day and olanzapine 50 mg/day for the last 3 years. As diabetes mellitus was diagnosed in follow-ups, interruption of olanzapine treatment was planned. The patient stated that she started taking the medicine again upon discomfort, increase in anxiety, dysphoria, insomnia, and nervousness, which started just after olanzapine was interrupted. She said that she was feeling dense stress when she did not take the medicine, and she thought that this situation would recover only by taking that medicine and hence she could not discontinue the medicine. In addition to medications with obvious abuse potential such as benzodiazepines and methylphenidate, and other stimulants, abuse of a number of commonly prescribed psychiatric medications has been reported. There are only 2 cases of olanzapine abuse in literature.
Title: Olanzapine Abuse
Description:
Olanzapine is a thienobenzodiazepine that blocks especially the serontonin (5-hydroxytryptamine [5-HT]) 5-HT2A and the dopamine D2 receptors as well as muscarinic (M1), histamine (H1), 5-HT2C, 5-HT3 to 5-HT6, adrenergic (αl), and D4 receptors.
This case report presents an olanzapine abuse.
A 48-year-old, primary school graduate, married woman applied to psychiatry clinic with tachycardia, insomnia, and anxiety complaints.
In psychiatric evaluations, it was determined that these complaints have been continuing for 15 years at intervals and that she has been using citalopram 40 mg/day and olanzapine 50 mg/day for the last 3 years.
As diabetes mellitus was diagnosed in follow-ups, interruption of olanzapine treatment was planned.
The patient stated that she started taking the medicine again upon discomfort, increase in anxiety, dysphoria, insomnia, and nervousness, which started just after olanzapine was interrupted.
She said that she was feeling dense stress when she did not take the medicine, and she thought that this situation would recover only by taking that medicine and hence she could not discontinue the medicine.
In addition to medications with obvious abuse potential such as benzodiazepines and methylphenidate, and other stimulants, abuse of a number of commonly prescribed psychiatric medications has been reported.
There are only 2 cases of olanzapine abuse in literature.
Related Results
Protective Role of Vitamin C and Silymarin Against Olanzapine-Induced Hepatotoxicity in Albino Rats: A Histopathological and Biochemical Study
Protective Role of Vitamin C and Silymarin Against Olanzapine-Induced Hepatotoxicity in Albino Rats: A Histopathological and Biochemical Study
Background:
Olanzapine is an atypical antipsychotic drug for treating bipolar disorders and Schizophrenia. Regardless of being used as a common antipsychotic
drug, there are report...
Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia
Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia
Objective To describe the approval of olanzapine/samidorphan, compare the clinical trial data, and summarize key findings, with a focus on impact to clinical practice. Data Sources...
Girl Child Sexual Abuse in Lusaka Urban
Girl Child Sexual Abuse in Lusaka Urban
The study on girl child sexual abuse and whose findings are presented in this article was conducted in 2010 as an academic requirement for the purpose of completing a Master’s degr...
Olanzapine, not resperidone, exacerbates β-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them
Olanzapine, not resperidone, exacerbates β-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them
The effect of risperidone and olanzapine on β-cell function and mass was investigated in 90% pancreatectomized and ovariectomized female rats, of which some were treated with estro...
Non-medical use of olanzapine by people on methadone treatment
Non-medical use of olanzapine by people on methadone treatment
Aims and methodWe examined non-medical use (NMU) of olanzapine among adults on methadone treatment. Information was collected on patient demographics and NMU of olanzapine. The Alc...
Roli i olanzapinës në modulimin e homeostazës kockore – hulumtim eksperimental paraklinik
Roli i olanzapinës në modulimin e homeostazës kockore – hulumtim eksperimental paraklinik
Long-term use of olanzapine may adversely affect oral health by disrupting bone homeostasis and increasing the risk of alveolar resorption and structural bone damage. This preclini...
Substance Abuse Education for Nurse Anesthetists: Differences in Knowledge of Substance Abuse between Student Nurse Anesthetists who have Completed a Substance Abuse Workshop and those who have Not
Substance Abuse Education for Nurse Anesthetists: Differences in Knowledge of Substance Abuse between Student Nurse Anesthetists who have Completed a Substance Abuse Workshop and those who have Not
The purpose of this study was to determine whether student nurse anesthetists who took a substance abuse workshop had more knowledge of substance abuse than those who did not take ...
Seizure Associated with Olanzapine
Seizure Associated with Olanzapine
OBJECTIVE: To report a case of seizures in a patient who started receiving olanzapine, and to review seizure risk associated with antipsychotic use. CASE SUMMARY: A 31-year-old Afr...

